AIxURO Technology Integration AIxMed's AIxURO ™ solution is specifically developed to assist in the analysis of non-invasive ...

AIxMed, an innovator in AI diagnostics for urine cytology and Lumea, a leading provider of primary clinical digital pathology solutions, announced a new partnership. This collaboration will integrate ...

Under the MOU, Biopticka will be designated as a reference site for AIxMed in Europe, demonstrating the real-world application of AIxURO™ to prospective partners and clients. Supported by AIxMed's ...

Cystoscopy and cytology remain the standard for diagnosis, but a plethora of urinary biomarkers could someday be a useful adjunct to NMIBC surveillance. Urine cytology, however, also has several known ...

PARIS & SÃO PAULO, Brazil--(BUSINESS WIRE)--Regulatory News: Ikonisys (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully ...